Xencor Inc Catalyst Calendar

Proactively evaluate Xencor Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Xencor Inc Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 50+ results. Subscribe to unlock more.
31 Dec 2020 GDCTXXXX Lorem Lorem Lorem XXXX Planned Lorem
30 Jun 2020 Phase I Trial Results ICON Plc; Xencor Inc ICLR; XNCR tidutamab Oncology Gastrointestinal Stromal Tumor (GIST); Gastrointestinal Tumor; Lung Cancer; Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET); Neuroendocrine Tumors; Pancreatic Cancer; Solid Tumor Company Press Release
31 Dec 2019 IND Filing (US) Xencor Inc XNCR XmAb-306 Oncology - Company Press Release
31 Dec 2019 Phase I Trial Results ICON Plc; Xencor Inc ICLR; XNCR plamotamab Hematological Disorders; Oncology B-Cell Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia (CLL); Diffuse Large B-Cell Lymphoma; Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma); Follicular Lymphoma; Hematological Tumor; Lymphoma; Mantle Cell Lymphoma; Nodal Marginal Zone B-Cell Lymphoma; Non-Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia (CLL); Relapsed Chronic Lymphocytic Leukemia (CLL); Splenic Marginal Zone B-Cell Lymphoma; Unspecified B-Cell Lymphomas; Unspecified Hematological Disorders; Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Company Presentation
Catalyst Calendar


Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.



  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)


Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.


Access more premium companies when you subscribe to Explorer